guanfacine has been researched along with Hypertrophy, Left Ventricular in 1 studies
Guanfacine: A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
Excerpt | Relevance | Reference |
---|---|---|
"The left ventricular end systolic stress-end systolic dimension (ESS-ESD) relation was used to assess the effect of regression in left ventricular hypertrophy on myocardial contractility in 14 hypertensive patients (mean age 47 years) treated with guanfacine (a sympatholytic central alpha-adrenergic agonist) for 10 weeks." | 3.67 | Contractile performance following regression of left ventricular hypertrophy in hypertensive patients. ( el-Said, G; Emile, H; Ibrahim, MM; Madkour, MA, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ibrahim, MM | 1 |
Emile, H | 1 |
Madkour, MA | 1 |
el-Said, G | 1 |
1 other study available for guanfacine and Hypertrophy, Left Ventricular
Article | Year |
---|---|
Contractile performance following regression of left ventricular hypertrophy in hypertensive patients.
Topics: Adult; Guanfacine; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardia | 1985 |